Wolverine Trading’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $29.9M | Buy |
1,255,100
+21,300
| +2% | +$526K | 0.02% | 470 |
|
|
2025
Q2 | $29.8M | Sell |
1,233,800
-266,000
| -18% | -$6.2M | 0.03% | 349 |
|
|
2025
Q1 | $37.8M | Buy |
1,499,800
+176,700
| +13% | +$4.62M | 0.04% | 262 |
|
|
2024
Q4 | $35M | Buy |
1,323,100
+65,600
| +5% | +$1.78M | 0.03% | 313 |
|
|
2024
Q3 | $36.6M | Buy |
1,257,500
+160,500
| +15% | +$4.68M | 0.04% | 270 |
|
|
2024
Q2 | $30.7M | Buy |
1,097,000
+233,000
| +27% | +$6.41M | 0.03% | 299 |
|
|
2024
Q1 | $24M | Buy |
864,000
+95,100
| +12% | +$2.64M | 0.02% | 363 |
|
|
2023
Q4 | $22.1M | Buy |
768,900
+255,500
| +50% | +$7.72M | 0.02% | 422 |
|
|
2023
Q3 | $17M | Buy |
513,400
+5,500
| +1% | +$194K | 0.02% | 426 |
|
|
2023
Q2 | $18.3M | Buy |
507,900
+25,800
| +5% | +$1M | 0.02% | 381 |
|
|
2023
Q1 | $19.5M | Buy |
+482,100
| New | +$20.8M | 0.03% | 353 |
|
|
2022
Q4 | – | Sell |
-508,100
| Closed | -$22.4M | – | 4786 |
|
|
2022
Q3 | $22.4M | Sell |
508,100
-71,400
| -12% | -$3.47M | 0.04% | 294 |
|
|
2022
Q2 | $29.5M | Sell |
579,500
-109,500
| -16% | -$5.58M | 0.05% | 217 |
|
|
2022
Q1 | $36.1M | Sell |
689,000
-14,000
| -2% | -$726K | 0.05% | 270 |
|
|
2021
Q4 | $41.1M | Buy |
703,000
+23,200
| +3% | +$1.15M | 0.05% | 268 |
|
|
2021
Q3 | $29.6M | Sell |
679,800
-72,200
| -10% | -$3.2M | 0.03% | 386 |
|
|
2021
Q2 | $29.4M | Buy |
752,000
+230,900
| +44% | +$8.98M | 0.05% | 297 |
|
|
2021
Q1 | $18.8M | Buy |
521,100
+211,400
| +68% | +$7.51M | 0.03% | 417 |
|
|
2020
Q4 | $11.4M | Sell |
309,700
-181,780
| -37% | -$6.67M | 0.02% | 622 |
|
|
2020
Q3 | $16.9M | Buy |
491,480
+47,219
| +11% | +$1.66M | 0.04% | 348 |
|
|
2020
Q2 | $13.8M | Buy |
444,261
+83,793
| +23% | +$2.85M | 0.04% | 356 |
|
|
2020
Q1 | $11.2M | Buy |
360,468
+32,147
| +10% | +$1.1M | 0.03% | 388 |
|
|
2019
Q4 | $12.1M | Sell |
328,321
-47,008
| -13% | -$1.67M | 0.03% | 588 |
|
|
2019
Q3 | $12.9M | Buy |
375,329
+92,646
| +33% | +$3.37M | 0.04% | 425 |
|
|
2019
Q2 | $11.6M | Sell |
282,683
-75,888
| -21% | -$3.01M | 0.03% | 466 |
|
|
2019
Q1 | $14.4M | Buy |
358,571
+41,739
| +13% | +$1.67M | 0.04% | 365 |
|
|
2018
Q4 | $12.9M | Buy |
316,832
+20,236
| +7% | +$840K | 0.04% | 378 |
|
|
2018
Q3 | $12.4M | Sell |
296,596
-41,106
| -12% | -$1.58M | 0.03% | 466 |
|
|
2018
Q2 | $11.4M | Hold |
337,702
| – | – | 0.03% | 443 |
|
|
2018
Q1 | $11.4M | Sell |
337,702
-15,388
| -4% | -$529K | 0.03% | 443 |
|
|
2017
Q4 | $12.1M | Sell |
353,090
-157,362
| -31% | -$5.37M | 0.04% | 423 |
|
|
2017
Q3 | $17.3M | Buy |
510,452
+14,861
| +3% | +$478K | 0.07% | 253 |
|
|
2017
Q2 | $15.8M | Buy |
495,591
+38,050
| +8% | +$1.2M | 0.07% | 240 |
|
|
2017
Q1 | $14.9M | Sell |
457,541
-49,960
| -10% | -$1.58M | 0.08% | 246 |
|
|
2016
Q4 | $15.6M | Sell |
507,501
-51,224
| -9% | -$1.56M | 0.08% | 270 |
|
|
2016
Q3 | $17.7M | Buy |
+558,725
| New | +$18.7M | 0.08% | 253 |
|
Other funds holding PFE
Wolverine Trading's PFE Position: Q3 2025 in Review
Wolverine Trading reduced its Pfizer (PFE) stake by 13% in Q3 2025, selling an estimated $275K and leaving 76,642 shares worth $1.83M. The position accounts for ﹤0.01% of the portfolio, ranked #2259.
Wolverine Trading first reported a position in PFE in Q3 2016 and has held it in 34 quarters since. The position peaked at $17.6M in Q4 2019. 2,811 funds tracked by Wall St. Rank hold PFE as of Q3 2025.
- Wolverine Trading held 76,642 shares of Pfizer worth $1.83M as of Q3 2025.
- Wolverine Trading sold 11,126 Pfizer shares in Q3 2025, an estimated $275K.
- Pfizer made up ﹤0.01% of Wolverine Trading's portfolio in Q3 2025, its #2259 holding.
- Wolverine Trading first reported a position in Pfizer in Q3 2016 and has held it in 34 quarters since.
- Wolverine Trading's Pfizer position peaked at $17.6M in Q4 2019.
- 2,811 funds tracked by Wall St. Rank held Pfizer as of Q3 2025.
Based on Wolverine Trading's 13F filing for Q3 2025, filed 14 Nov 2025.